T1	CHEM 57 76	Ozuriftamab Vedotin
T2	CHEM 78 84	BA3021
T3	CHEM 112 121	Nivolumab
#1	AnnotatorNotes T3	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T4	LIVB 125 134	pacientes
#2	AnnotatorNotes T4	C0030705; Patients; Patient or Disabled Group
T5	DISO 139 154	tumores sólidos
#3	AnnotatorNotes T5	C0280100; Solid Neoplasm; Neoplastic Process
T6	PROC 187 206	Estudio de fase 1/2
T7	PROC 210 242	aumento y ampliación de la dosis
T8	CHEM 246 265	ozuriftamab vedotin
T9	CHEM 267 273	BA3021
T10	PROC 278 289	monoterapia
#4	AnnotatorNotes T10	C4763675; Single Agent Therapy; Therapeutic or Preventive Procedure
T11	CHEM 311 320	nivolumab
#5	AnnotatorNotes T11	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T12	LIVB 324 333	pacientes
#6	AnnotatorNotes T12	C0030705; Patients; Patient or Disabled Group
T13	DISO 338 353	tumores sólidos
#7	AnnotatorNotes T13	C0280100; Solid Neoplasm; Neoplastic Process
T14	DISO 397 412	Tumores sólidos
#8	AnnotatorNotes T14	C0280100; Solid Neoplasm; Neoplastic Process
T15	LIVB 463 472	pacientes
#9	AnnotatorNotes T15	C0030705; Patients; Patient or Disabled Group
T16	DISO 492 523	cáncer de pulmón no microcítico
#10	AnnotatorNotes T16	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T17	Neg_cue 509 511	no
T18	Negated 512 523	microcítico
T19	DISO 525 529	CPNM
#11	AnnotatorNotes T19	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T20	DISO 533 541	melanoma
#12	AnnotatorNotes T20	C0025202; melanoma; Neoplastic Process
T21	DISO 577 588	metastásico
#13	AnnotatorNotes T21	C4255448; Metastasis; Pathologic Function
T22	PROC 601 630	histológica o citológicamente
T23	Age 639 647	≥18 años
T24	PHYS 651 664	Función renal
#14	AnnotatorNotes T24	C0232804; Renal function; Organ or Tissue Function
T25	PHYS 677 693	Función hepática
T26	PHYS 706 726	Función hematológica
T27	Duration 847 863	al menos 3 meses
T28	DISO 892 903	Cardiopatía
#15	AnnotatorNotes T28	C0018799; Heart Diseases; Disease or Syndrome
T29	DISO 947 957	metástasis
#16	AnnotatorNotes T29	C0027627; Neoplasm Metastasis; Neoplastic Process | C2939419; Secondary Neoplasm; Neoplastic Process
T30	Neg_cue 958 961	sin
T31	Negated 962 1002	controlar en el sistema nervioso central
T32	ANAT 978 1002	sistema nervioso central
#17	AnnotatorNotes T32	C1269563; Entire central nervous system; Body System | C3714787; Central Nervous System; Body System
T33	PROC 1006 1017	Tratamiento
#18	AnnotatorNotes T33	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T34	CHEM 1032 1058	derivado de la auristatina
T35	Neg_cue 1072 1075	sin
T36	Negated 1076 1084	conjugar
T37	CHEM 1137 1142	vinca
T38	DISO 1162 1182	reacciones alérgicas
#19	AnnotatorNotes T38	C0020517; Hypersensitivity; Pathologic Function | C1527304; Allergic Reaction; Pathologic Function
T39	PROC 1198 1209	tratamiento
#20	AnnotatorNotes T39	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T40	CHEM 1214 1217	AcM
#21	AnnotatorNotes T40	C0003250; Monoclonal Antibodies; Amino Acid, Peptide, or Protein · Immunologic Factor
T41	Spec_cue 1240 1251	sospecha de
T42	DISO 1252 1259	alergia
#22	AnnotatorNotes T42	C0020517; Hypersensitivity; Pathologic Function
T43	Speculated 1252 1259	alergia
T44	DISO 1262 1274	intolerancia
T45	Speculated 1262 1274	intolerancia
T46	CHEM 1295 1307	medicamentos
#23	AnnotatorNotes T46	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0304228; Proprietary drug, NOS; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T47	PROC 1375 1404	intervención de cirugía mayor
T48	Duration 1425 1438	las 4 semanas
T49	PROC 1463 1477	administración
#24	AnnotatorNotes T49	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T50	CHEM 1481 1487	BA3021
T51	PROC 1531 1579	pruebas del virus de la inmunodeficiencia humana
T52	DISO 1581 1584	VIH
#25	AnnotatorNotes T52	C0458074; Human immunodeficiency virus (HIV) status; Finding
T53	DISO 1602 1641	síndrome de inmunodeficiencia adquirida
#26	AnnotatorNotes T53	C0001175; Acquired Immunodeficiency Syndrome; Disease or Syndrome
T54	DISO 1643 1647	sida
#27	AnnotatorNotes T54	C0001175; Acquired Immunodeficiency Syndrome; Disease or Syndrome
T55	LIVB 1652 1697	Mujeres embarazadas o en período de lactancia
